PATENT CLAIM ANALYSIS

Application Number: 16454319
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a T max  of meloxicam of 3 hours or less.

Claim (Index 8):
The method of  claim 1 , wherein the solid dosage form contains about 400 mg to about 600 mg of the bicarbonate.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 2.09722
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16248449', '16440695', '16247406', '15986215', '15902770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8069553130582839
- 35 USC 102 Novelty (BERT): 0.5787266222595145
- Combined Prediction Score: 0.784132443978407
- Mean Citation Score: 444.79049
- Max Citation Score: 457.075
- Similarity Product: 423.88966265916815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test